Patents by Inventor Kenneth G. Olson

Kenneth G. Olson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190194765
    Abstract: Systems and methods for detecting and/or identifying target cells (e.g., bacteria) using engineered transduction particles are described herein. In some embodiments, a method includes mixing a quantity of transduction particles within a sample. The transduction particles are associated with a target cell. The transduction particles are non-replicative, and are engineered to include a nucleic acid molecule formulated to cause the target cell to produce a series of reporter molecules. The sample and the transduction particles are maintained to express the series of the reporter molecules when target cell is present in the sample. A signal associated with a quantity of the reporter molecules is received. In some embodiments, a magnitude of the signal is independent from a quantity of the transduction particle above a predetermined quantity.
    Type: Application
    Filed: February 27, 2019
    Publication date: June 27, 2019
    Applicant: GeneWeave Biosciences, Inc.
    Inventors: Diego Ariel REY, Shaunak ROY, Leonardo Maestri TEIXEIRA, Ryan C. GRISWOLD, Kenneth G. OLSON, Bruce J. RICHARDSON, Victor H. YEE, Werner FREI
  • Patent number: 10240212
    Abstract: Systems and methods for detecting and/or identifying target cells (e.g., bacteria) using engineered transduction particles are described herein. In some embodiments, a method includes mixing a quantity of transduction particles within a sample. The transduction particles are associated with a target cell. The transduction particles are non-replicative, and are engineered to include a nucleic acid molecule formulated to cause the target cell to produce a series of reporter molecules. The sample and the transduction particles are maintained to express the series of the reporter molecules when target cell is present in the sample. A signal associated with a quantity of the reporter molecules is received. In some embodiments, a magnitude of the signal is independent from a quantity of the transduction particle above a predetermined quantity.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: March 26, 2019
    Assignee: GeneWeave Biosciences, Inc.
    Inventors: Diego Ariel Rey, Shaunak Roy, Leonardo Maestri Teixeira, Ryan C. Griswold, Kenneth G. Olson, Bruce J. Richardson, Victor H. Yee, Werner Frei
  • Patent number: 10125386
    Abstract: An apparatus includes a housing and an actuator. The housing, which defines a reagent volume that can receive a reagent container, can be removably coupled to a reaction chamber. The housing includes a puncturer that defines a transfer pathway in fluid communication with the reagent volume. A delivery portion of the housing defines a delivery pathway between the transfer pathway and the reaction chamber when the housing is coupled to the reaction chamber. The actuator has a plunger portion disposed within the reagent volume. An engagement portion of the actuator can be manipulated to move the plunger portion within the reagent volume to deform the reagent container. The puncturer can pierce a frangible portion of the reagent container to convey a reagent from the reagent container into the reaction chamber via the transfer pathway and/or the delivery pathway.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: November 13, 2018
    Assignee: GeneWeave Biosciences, Inc.
    Inventors: Nikol De Forest, Werner Frei, Diego Rey, Shaunak Roy, Soni Shukla, Ryan C. Griswold, Kenneth G. Olson, Bruce J. Richardson, Victor H. Yee
  • Publication number: 20170233783
    Abstract: An apparatus includes a housing and an actuator. The housing, which defines a reagent volume that can receive a reagent container, can be removably coupled to a reaction chamber. The housing includes a puncturer that defines a transfer pathway in fluid communication with the reagent volume. A delivery portion of the housing defines a delivery pathway between the transfer pathway and the reaction chamber when the housing is coupled to the reaction chamber. The actuator has a plunger portion disposed within the reagent volume. An engagement portion of the actuator can be manipulated to move the plunger portion within the reagent volume to deform the reagent container. The puncturer can pierce a frangible portion of the reagent container to convey a reagent from the reagent container into the reaction chamber via the transfer pathway and/or the delivery pathway.
    Type: Application
    Filed: November 30, 2016
    Publication date: August 17, 2017
    Applicant: GeneWeave Biosciences, Inc.
    Inventors: Nikol DE FOREST, Werner FREI, Diego Rey, Shaunak Roy, Soni SHUKLA, Ryan C. GRISWOLD, Kenneth G. OLSON, Bruce J. RICHARDSON, Victor H. Yee
  • Publication number: 20170152576
    Abstract: Systems and methods for detecting and/or identifying target cells (e.g., bacteria) using engineered transduction particles are described herein. In some embodiments, a method includes mixing a quantity of transduction particles within a sample. The transduction particles are associated with a target cell. The transduction particles are non-replicative, and are engineered to include a nucleic acid molecule formulated to cause the target cell to produce a series of reporter molecules. The sample and the transduction particles are maintained to express the series of the reporter molecules when target cell is present in the sample. A signal associated with a quantity of the reporter molecules is received. In some embodiments, a magnitude of the signal is independent from a quantity of the transduction particle above a predetermined quantity.
    Type: Application
    Filed: December 22, 2016
    Publication date: June 1, 2017
    Applicant: GeneWeave Biosciences, Inc.
    Inventors: Diego Ariel REY, Shaunak ROY, Leonardo Maestri TEIXEIRA, Ryan C. GRISWOLD, Kenneth G. OLSON, Bruce J. RICHARDSON, Victor H. YEE
  • Patent number: 9546391
    Abstract: Systems and methods for detecting and/or identifying target cells (e.g., bacteria) using engineered transduction particles are described herein. In some embodiments, a method includes mixing a quantity of transduction particles within a sample. The transduction particles are associated with a target cell. The transduction particles are non-replicative, and are engineered to include a nucleic acid molecule formulated to cause the target cell to produce a series of reporter molecules. The sample and the transduction particles are maintained to express the series of the reporter molecules when target cell is present in the sample. A signal associated with a quantity of the reporter molecules is received. In some embodiments, a magnitude of the signal is independent from a quantity of the transduction particle above a predetermined quantity.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: January 17, 2017
    Assignee: GeneWeave Biosciences, Inc.
    Inventors: Diego Ariel Rey, Shaunak Roy, Werner Frei, Bruce J. Richardson, Ryan C. Griswold, Damian S. Matthews, Kenneth G. Olson, Victor H. Yee
  • Patent number: 9540675
    Abstract: An apparatus includes a housing and an actuator. The housing, which defines a reagent volume that can receive a reagent container, can be removably coupled to a reaction chamber. The housing includes a puncturer that defines a transfer pathway in fluid communication with the reagent volume. A delivery portion of the housing defines a delivery pathway between the transfer pathway and the reaction chamber when the housing is coupled to the reaction chamber. The actuator has a plunger portion disposed within the reagent volume. An engagement portion of the actuator can be manipulated to move the plunger portion within the reagent volume to deform the reagent container. The puncturer can pierce a frangible portion of the reagent container to convey a reagent from the reagent container into the reaction chamber via the transfer pathway and/or the delivery pathway.
    Type: Grant
    Filed: February 9, 2015
    Date of Patent: January 10, 2017
    Assignee: GeneWeave Biosciences, Inc.
    Inventors: Nikol De Forest, Werner Frei, Diego Rey, Shaunak Roy, Soni Shukla, Ryan C. Griswold, Kenneth G. Olson, Bruce J. Richardson, Victor H. Yee
  • Patent number: 9481903
    Abstract: Systems and methods for detecting and/or identifying target cells (e.g., bacteria) using engineered transduction particles are described herein. In some embodiments, a method includes mixing a quantity of transduction particles within a sample. The transduction particles are associated with a target cell. The transduction particles are non-replicative, and are engineered to include a nucleic acid molecule formulated to cause the target cell to produce a series of reporter molecules. The sample and the transduction particles are maintained to express the series of the reporter molecules when target cell is present in the sample. A signal associated with a quantity of the reporter molecules is received. In some embodiments, a magnitude of the signal is independent from a quantity of the transduction particle above a predetermined quantity.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: November 1, 2016
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Diego Ariel Rey, Shaunak Roy, Leonardo Maestri Teixeira, Ryan C. Griswold, Kenneth G. Olson, Bruce J. Richardson, Victor Yee
  • Patent number: 9133497
    Abstract: Systems and methods for detecting and/or identifying target cells (e.g., bacteria) using engineered transduction particles are described herein. In some embodiments, a method includes mixing a quantity of transduction particles within a sample. The transduction particles are associated with a target cell. The transduction particles are non-replicative, and are engineered to include a nucleic acid molecule formulated to cause the target cell to produce a series of reporter molecules. The sample and the transduction particles are maintained to express the series of the reporter molecules when target cell is present in the sample. A signal associated with a quantity of the reporter molecules is received. In some embodiments, a magnitude of the signal is independent from a quantity of the transduction particle above a predetermined quantity.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: September 15, 2015
    Assignee: GeneWeave Biosciences, Inc.
    Inventors: Werner Frei, Diego Ariel Rey, Shaunak Roy, Ryan C. Griswold, Kenneth G. Olson, Bruce J. Richardson, Rick V. Stellmacher
  • Publication number: 20150218613
    Abstract: An apparatus includes a housing and an actuator. The housing, which defines a reagent volume that can receive a reagent container, can be removably coupled to a reaction chamber. The housing includes a puncturer that defines a transfer pathway in fluid communication with the reagent volume. A delivery portion of the housing defines a delivery pathway between the transfer pathway and the reaction chamber when the housing is coupled to the reaction chamber. The actuator has a plunger portion disposed within the reagent volume. An engagement portion of the actuator can be manipulated to move the plunger portion within the reagent volume to deform the reagent container. The puncturer can pierce a frangible portion of the reagent container to convey a reagent from the reagent container into the reaction chamber via the transfer pathway and/or the delivery pathway.
    Type: Application
    Filed: February 9, 2015
    Publication date: August 6, 2015
    Applicant: GeneWeave Biosciences, Inc.
    Inventors: Nikol DE FOREST, Werner FREI, Diego REY, Shaunak ROY, Soni SHUKLA, Ryan C. GRISWOLD, Kenneth G. OLSON, Bruce J. RICHARDSON, Victor H. YEE
  • Publication number: 20150148261
    Abstract: Systems and methods for detecting and/or identifying target cells (e.g., bacteria) using engineered transduction particles are described herein. In some embodiments, a method includes mixing a quantity of transduction particles within a sample. The transduction particles are associated with a target cell. The transduction particles are non-replicative, and are engineered to include a nucleic acid molecule formulated to cause the target cell to produce a series of reporter molecules. The sample and the transduction particles are maintained to express the series of the reporter molecules when target cell is present in the sample. A signal associated with a quantity of the reporter molecules is received. In some embodiments, a magnitude of the signal is independent from a quantity of the transduction particle above a predetermined quantity.
    Type: Application
    Filed: February 2, 2015
    Publication date: May 28, 2015
    Applicant: GENEWEAVE BIOSCIENCES, INC.
    Inventors: Werner FREI, Diego Ariel REY, Shaunak ROY, Ryan C. GRISWOLD, Kenneth G. OLSON, Bruce J. RICHARDSON, Rick V. STELLMACHER
  • Publication number: 20140273180
    Abstract: Systems and methods for detecting and/or identifying target cells (e.g., bacteria) using engineered transduction particles are described herein. In some embodiments, a method includes mixing a quantity of transduction particles within a sample. The transduction particles are associated with a target cell. The transduction particles are non-replicative, and are engineered to include a nucleic acid molecule formulated to cause the target cell to produce a series of reporter molecules. The sample and the transduction particles are maintained to express the series of the reporter molecules when target cell is present in the sample. A signal associated with a quantity of the reporter molecules is received. In some embodiments, a magnitude of the signal is independent from a quantity of the transduction particle above a predetermined quantity.
    Type: Application
    Filed: October 8, 2013
    Publication date: September 18, 2014
    Applicant: GENEWEAVE BIOSCIENCES, INC.
    Inventors: Ryan C. GRISWOLD, Kenneth G. OLSON, Bruce J. RICHARDSON, Rick V. STELLMACHER, Victor H. YEE
  • Patent number: 8829473
    Abstract: Systems and methods for detecting and/or identifying target cells (e.g., bacteria) using engineered transduction particles are described herein. In some embodiments, a method includes mixing a quantity of transduction particles within a sample. The transduction particles are associated with a target cell. The transduction particles are non-replicative, and are engineered to include a nucleic acid molecule formulated to cause the target cell to produce a series of reporter molecules. The sample and the transduction particles are maintained to express the series of the reporter molecules when target cell is present in the sample. A signal associated with a quantity of the reporter molecules is received. In some embodiments, a magnitude of the signal is independent from a quantity of the transduction particle above a predetermined quantity.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: September 9, 2014
    Assignee: GeneWeave Biosciences, Inc.
    Inventors: Ryan C. Griswold, Kenneth G. Olson, Bruce J. Richardson, Rick V. Stellmacher, Victor H. Yee
  • Patent number: 6320960
    Abstract: A headset has an earpiece and a flexible microphone boom. The headset is designed and constructed to be lightweight, flexibly adjustable, and comfortable to wear. The earpiece fits comfortably over an external portion of an ear of a wearer and between a head of the wearer and the ear. The earpiece is designed to be easily adjusted for a secure, comfortable fit. In the preferred embodiment, the earpiece includes a rigid plastic backbone and a ductile wire. In an alternate embodiment, the earpiece includes a rigid plastic backbone, a spring, and a ductile wire. The earpiece has an asymmetrical U shape, facilitating easy adjustment to fit securely around the external portion of the ear. A speaker module is coupled to the earpiece and designed to rest over a pinna of the ear when the earpiece is worn over the ear. A small speaker is mounted inside the speaker module. The speaker module is coupled to the earpiece by a ball and socket joint integrally formed as part of the earpiece.
    Type: Grant
    Filed: September 24, 1999
    Date of Patent: November 20, 2001
    Assignee: Hello Direct, Inc.
    Inventors: Robert L. Lathrop, III, Richard J. Lutzinger, Kenneth G. Olson, John H. Magnasco
  • Patent number: 5820957
    Abstract: An anti-reflective film construction contains an optically transparent polymeric film having a textured surface and an optically transparent adhesive, the film construction configured to exhibit light transmission of greater than about 70 percent and 60.degree. gloss measurement of between about 15 and 100. Methods of producing such film constructions and methods of reducing reflection from a surface are also described.
    Type: Grant
    Filed: May 6, 1996
    Date of Patent: October 13, 1998
    Assignee: Minnesota Mining and Manufacturing Company
    Inventors: Kristin M. Schroeder, Brian L. Koster, Timothy T. Magill, Kenneth G. Olson, Takashi Harada
  • Patent number: D436095
    Type: Grant
    Filed: September 24, 1999
    Date of Patent: January 9, 2001
    Assignee: Hello Direct, Inc.
    Inventors: Peter Otto Schmidt, Robert L. Lathrop, III, Richard J. Lutzinger, Kenneth G. Olson, John H. Magnasco
  • Patent number: D387867
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: December 16, 1997
    Assignee: Acuson Corporation
    Inventors: Richard W. Henderson, Robert Mesaros, Michael J. Conroy, Kenneth G. Olson
  • Patent number: D389912
    Type: Grant
    Filed: November 27, 1996
    Date of Patent: January 27, 1998
    Assignee: Eclipse Surgical Technologies, Inc.
    Inventors: Rick Emerson, Kenneth G. Olson, Stuart D. Harman, Steven A. Daniel
  • Patent number: D389915
    Type: Grant
    Filed: November 27, 1996
    Date of Patent: January 27, 1998
    Assignee: Eclipse Surgical Technologies, Inc.
    Inventors: Rick Emerson, Kenneth G. Olson, Steven A. Daniel
  • Patent number: D405883
    Type: Grant
    Filed: December 23, 1996
    Date of Patent: February 16, 1999
    Assignee: Eclipse Surgical Technologies, Inc.
    Inventors: Rick Emerson, Kenneth G. Olson, Gabriele Bungardt, Stuart D. Harman